University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
基本信息
- 批准号:9754231
- 负责人:
- 金额:$ 65.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAfricanAsiansBangladeshBirth WeightCessation of lifeChildChild DevelopmentChild HealthChronicClinicalClinical ProtocolsClinical ResearchClinical TrialsClinical trial protocol documentCollaborationsCommunicable DiseasesCommunitiesComplementCoordination and CollaborationCountryDataDevelopmentDevelopmental Delay DisordersDiarrheaEnteralEnvironmentFacility AccessesFailureFunctional disorderGoalsGovernmentGrantHealthHealth StatusHuman GeneticsImmunologyImpairmentIncomeInfant MalnutritionInfectionInflammationInstitutesInternationalInterventionKnowledgeLeadLeadershipLive BirthMalnutritionMaternal MortalityMaternal and Child HealthMaternal-fetal medicineModelingMothersMucous MembraneNeonatalNeonatal MortalityNeonatologyNeurocognitiveObservational StudyOralParasitologyPositioning AttributePregnancyPregnant WomenPrincipal InvestigatorPublic HealthPublicationsRecording of previous eventsRehydration SolutionsResearchResearch Peer ReviewResearch PersonnelRespiratory Tract InfectionsRoleRotavirus VaccinesRuralRural PopulationScientistSiteSustainable DevelopmentTestingUnited NationsUniversitiesUrban PopulationVaccinesVirginiaWeight GainWomanWorkauthoritybasecommunity based caredietary supplementsexperienceglobal healthimprovedinfant nutritioninnovationinventionlaboratory facilitymicrobiomemolecular diagnosticsmortalitymultidisciplinaryneurodevelopmentnovelnutritionoral vaccinepollutantpopulation healthpreventvaccinology
项目摘要
Project Summary
We propose that the University of Virginia (UVa) and icddr,b become a Research Unit (RU) within the Global
Network for Women's and Children's Health Research.
Significance: Mothers and children in Bangladesh and other low-mid income countries suffer disproportionately
from maternal and infant malnutrition, neonatal mortality from diarrhea and respiratory infections, vaccine
failure and impaired child development. The UVa-icddrb Research Unit (RU) will address these critical needs
of women and young children by complementing the existing Network strengths with added scientific expertise
in infectious diseases, neurocognitive development, human genetics, maternal-fetal medicine, immunology,
and vaccinology. The RU will also provide extraordinary access to rural and urban populations for clinical trials.
Investigators: The RU Principal Investigator (PI) William Petri and Senior Foreign Investigator (SFI) Rashidul
Haque have for 25 years co-led multidisciplinary teams studying maternal-child, with over 100 co-publications
and eight on-going clinical trials or observational studies. They are joined at icddr,b by a multidisciplinary team
of F. Qadri (Immunology), K. Zaman (Vaccinology), F. Tofail (Child Development), M. Billah and S. El Arifeen
(Maternal and Child Health), T. Ahmed (infant nutrition) and at UVa by C. Chisholm (ob/gyn) and R. Sinkin
(neonatology).
Innovation: The RU has a long history of innovative studies and expertise in maternal-child health, including
the impact of infection and inflammation on child neurocognitive development, role of airborne pollutants on
respiratory infection, function of gut damage in oral vaccine failure and malnutrition.
Approach: The RU will work within the Network to promote innovative studies that have the potential to lead to
actionable and sustainable improvement in maternal and child health through the partnership of the RU with
the government of Bangladesh (manifest through the worldwide implementation of oral rehydration solution,
discovered at icddr,b and adoption nationwide of the Matlab model of community based care).
Environment: The RU has unparalleled multidisciplinary strength, laboratory facilities and access to urban
and rural populations of mothers and children. The icddr,b is one of the foremost global health institutes in
the developing world with over 200 active clinical trials/protocols. The UVa Division of Infectious Diseases
and International Health is the largest research unit at UVa with over $20 million in annual grant support and
over two dozen active clinical protocols. The quarter of a century UVa-icddrb collaboration and unique and
complementary expertise promises to bring unparalleled strengths to the Network's goal of making
sustainable improvements in maternal and child health.
项目摘要
我们建议弗吉尼亚大学(UVA)和ICDDR,B成为全球的研究部门(RU)
妇女和儿童健康研究网络。
意义:孟加拉国和其他低中收入国家的母亲和儿童遭受不成比例的
从母亲和婴儿营养不良,腹泻和呼吸道感染的新生儿死亡率,疫苗
失败和儿童发展受损。 UVA-ICDDRB研究部(RU)将满足这些关键需求
通过增添科学专业知识的现有网络优势,妇女和幼儿的妇女和幼儿
在传染病,神经认知发展,人类遗传学,母亲医学,免疫学,免疫学,
和疫苗学。 RU还将为临床试验提供非凡的访问农村和城市人口。
调查人员:RU首席研究员(PI)William Petri和外国高级研究员(SFI)Rashidul
Haque拥有25年的共同领导的多学科团队,他们研究母亲,共有100多个共同出版物
以及八项正在进行的临床试验或观察性研究。他们由一个多学科团队加入ICDDR,B
F. Qadri(免疫学),K。Zaman(疫苗学),F。Tofail(儿童发展),M。Billah和S. El Arifeen
(母亲和儿童健康),T。Ahmed(婴儿营养)以及C. Chisholm(OB/Gyn)和R. Sinkin的UVA
(新生儿学)。
创新:RU在孕产妇健康方面拥有创新研究和专业知识的悠久历史,包括
感染和炎症对儿童神经认知发展的影响,空中污染物对
呼吸道感染,口服疫苗衰竭和营养不良中肠道损伤的功能。
方法:RU将在网络内部工作,以促进有可能导致的创新研究
通过与RU与RU与与
孟加拉国政府(通过全球实施口服补液解决方案,明显
在ICDDR,B,B和MATLAB基于社区护理的MATLAB模型的采用中发现)。
环境:RU具有无与伦比的多学科力量,实验室设施和进入城市的通道
以及母亲和儿童的农村人口。 ICDDR,B是最重要的全球卫生研究所之一
具有200多种主动临床试验/方案的发展中国家。 UVA传染病分部
国际卫生是UVA最大的研究部门,拥有超过2000万美元的年度赠款支持和
超过二十多个主动临床方案。四分之一世纪的UVA-ICDDRB协作和独特的和
互补的专业知识有望为网络的目标带来无与伦比的优势
孕产妇健康的可持续改善。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William A Petri其他文献
William A Petri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William A Petri', 18)}}的其他基金
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10223165 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10653065 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10443698 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
10176548 - 财政年份:2018
- 资助金额:
$ 65.17万 - 项目类别:
NICHD Global Network for Women’s and Children’s Health Research: Research Units
NICHD 全球妇女和儿童健康研究网络:研究单位
- 批准号:
10746195 - 财政年份:2018
- 资助金额:
$ 65.17万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
10413887 - 财政年份:2018
- 资助金额:
$ 65.17万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10467414 - 财政年份:2016
- 资助金额:
$ 65.17万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10561651 - 财政年份:2016
- 资助金额:
$ 65.17万 - 项目类别:
Role of IL-23 in the Immunopathogenesis of C. difficile colitis
IL-23 在艰难梭菌结肠炎免疫发病机制中的作用
- 批准号:
9057951 - 财政年份:2015
- 资助金额:
$ 65.17万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
- 批准号:
10761853 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
- 批准号:
10735201 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
加强药物管理以控制非裔美国人和拉丁裔的 ADRD 风险因素
- 批准号:
10610975 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
UnityPhilly Response App for Overdose Reversal: Assessing Citywide Effectiveness and Sustainability
UnityPhilly 逆转用药过量响应应用程序:评估全市范围的有效性和可持续性
- 批准号:
10585638 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Support for Vector Biology Training for Sustainable Control of Vector Borne diseases in East Africa
支持媒介生物学培训以可持续控制东非媒介传播疾病
- 批准号:
10675897 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别: